Your browser doesn't support javascript.
loading
Key Residues at Third CDR3ß Position Impact Structure and Antigen Recognition of Human Invariant NK TCRs.
Chamoto, Kenji; Guo, Tingxi; Scally, Stephen W; Kagoya, Yuki; Anczurowski, Mark; Wang, Chung-Hsi; Rahman, Muhammed A; Saso, Kayoko; Butler, Marcus O; Chiu, Priscilla P L; Julien, Jean-Philippe; Hirano, Naoto.
Afiliación
  • Chamoto K; Tumor Immunotherapy Program, Campbell Family Institute for Breast Cancer Research, Campbell Family Cancer Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada.
  • Guo T; Tumor Immunotherapy Program, Campbell Family Institute for Breast Cancer Research, Campbell Family Cancer Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada.
  • Scally SW; Department of Immunology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
  • Kagoya Y; Program in Molecular Structure and Function, The Hospital for Sick Children Research Institute, Toronto, Ontario M5G 0A4, Canada.
  • Anczurowski M; Tumor Immunotherapy Program, Campbell Family Institute for Breast Cancer Research, Campbell Family Cancer Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada.
  • Wang CH; Tumor Immunotherapy Program, Campbell Family Institute for Breast Cancer Research, Campbell Family Cancer Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada.
  • Rahman MA; Department of Immunology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
  • Saso K; Tumor Immunotherapy Program, Campbell Family Institute for Breast Cancer Research, Campbell Family Cancer Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada.
  • Butler MO; Department of Immunology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
  • Chiu PP; Tumor Immunotherapy Program, Campbell Family Institute for Breast Cancer Research, Campbell Family Cancer Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada.
  • Julien JP; Tumor Immunotherapy Program, Campbell Family Institute for Breast Cancer Research, Campbell Family Cancer Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada.
  • Hirano N; Tumor Immunotherapy Program, Campbell Family Institute for Breast Cancer Research, Campbell Family Cancer Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 2M9, Canada.
J Immunol ; 198(3): 1056-1065, 2017 02 01.
Article en En | MEDLINE | ID: mdl-28003379
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Células T Asesinas Naturales / Antígenos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Immunol Año: 2017 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Células T Asesinas Naturales / Antígenos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Immunol Año: 2017 Tipo del documento: Article País de afiliación: Canadá